nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—CYP2D6—Alzheimer's disease	0.351	1	CbGaD
Oxprenolol—SLC22A2—Memantine—Alzheimer's disease	0.279	0.544	CbGbCtD
Oxprenolol—CYP2D6—Rivastigmine—Alzheimer's disease	0.101	0.197	CbGbCtD
Oxprenolol—CYP2D6—Donepezil—Alzheimer's disease	0.0807	0.157	CbGbCtD
Oxprenolol—CYP2D6—Galantamine—Alzheimer's disease	0.052	0.101	CbGbCtD
Oxprenolol—Coldness—Donepezil—Alzheimer's disease	0.0146	0.138	CcSEcCtD
Oxprenolol—Feeling cold—Donepezil—Alzheimer's disease	0.00789	0.0748	CcSEcCtD
Oxprenolol—Abnormal dreams—Donepezil—Alzheimer's disease	0.00223	0.0211	CcSEcCtD
Oxprenolol—Cardiac failure—Galantamine—Alzheimer's disease	0.00216	0.0205	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00193	0.0183	CcSEcCtD
Oxprenolol—Cardiac failure—Donepezil—Alzheimer's disease	0.00168	0.0159	CcSEcCtD
Oxprenolol—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00168	0.0159	CcSEcCtD
Oxprenolol—Psychotic disorder—Donepezil—Alzheimer's disease	0.0016	0.0152	CcSEcCtD
Oxprenolol—Cardiac failure—Memantine—Alzheimer's disease	0.00152	0.0144	CcSEcCtD
Oxprenolol—Hypoglycaemia—Memantine—Alzheimer's disease	0.00152	0.0144	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00149	0.0142	CcSEcCtD
Oxprenolol—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00149	0.0141	CcSEcCtD
Oxprenolol—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00149	0.0141	CcSEcCtD
Oxprenolol—Bradycardia—Galantamine—Alzheimer's disease	0.00149	0.0141	CcSEcCtD
Oxprenolol—Diplopia—Memantine—Alzheimer's disease	0.00149	0.0141	CcSEcCtD
Oxprenolol—Diplopia—Rivastigmine—Alzheimer's disease	0.00145	0.0138	CcSEcCtD
Oxprenolol—Psychotic disorder—Memantine—Alzheimer's disease	0.00145	0.0138	CcSEcCtD
Oxprenolol—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00142	0.0135	CcSEcCtD
Oxprenolol—Sweating increased—Donepezil—Alzheimer's disease	0.00138	0.0131	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00136	0.0129	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00133	0.0126	CcSEcCtD
Oxprenolol—Bronchospasm—Memantine—Alzheimer's disease	0.00126	0.012	CcSEcCtD
Oxprenolol—Sweating increased—Memantine—Alzheimer's disease	0.00125	0.0119	CcSEcCtD
Oxprenolol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00124	0.0117	CcSEcCtD
Oxprenolol—Sweating increased—Rivastigmine—Alzheimer's disease	0.00122	0.0116	CcSEcCtD
Oxprenolol—Bradycardia—Donepezil—Alzheimer's disease	0.00115	0.0109	CcSEcCtD
Oxprenolol—Palpitations—Galantamine—Alzheimer's disease	0.00112	0.0107	CcSEcCtD
Oxprenolol—Arthralgia—Galantamine—Alzheimer's disease	0.00108	0.0103	CcSEcCtD
Oxprenolol—Bradycardia—Memantine—Alzheimer's disease	0.00105	0.00992	CcSEcCtD
Oxprenolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.00102	0.00971	CcSEcCtD
Oxprenolol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00102	0.00964	CcSEcCtD
Oxprenolol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.001	0.00951	CcSEcCtD
Oxprenolol—Hypotension—Galantamine—Alzheimer's disease	0.00097	0.0092	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000946	0.00897	CcSEcCtD
Oxprenolol—Insomnia—Galantamine—Alzheimer's disease	0.000939	0.0089	CcSEcCtD
Oxprenolol—Dyspepsia—Galantamine—Alzheimer's disease	0.000914	0.00866	CcSEcCtD
Oxprenolol—Fatigue—Galantamine—Alzheimer's disease	0.000895	0.00849	CcSEcCtD
Oxprenolol—Arthralgia—Donepezil—Alzheimer's disease	0.000839	0.00796	CcSEcCtD
Oxprenolol—Abdominal pain—Galantamine—Alzheimer's disease	0.000821	0.00778	CcSEcCtD
Oxprenolol—Palpitations—Memantine—Alzheimer's disease	0.000791	0.0075	CcSEcCtD
Oxprenolol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000788	0.00747	CcSEcCtD
Oxprenolol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000778	0.00737	CcSEcCtD
Oxprenolol—Palpitations—Rivastigmine—Alzheimer's disease	0.000774	0.00734	CcSEcCtD
Oxprenolol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000765	0.00725	CcSEcCtD
Oxprenolol—Arthralgia—Memantine—Alzheimer's disease	0.000762	0.00722	CcSEcCtD
Oxprenolol—Hypotension—Donepezil—Alzheimer's disease	0.000752	0.00713	CcSEcCtD
Oxprenolol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000745	0.00707	CcSEcCtD
Oxprenolol—Asthenia—Galantamine—Alzheimer's disease	0.000745	0.00706	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000733	0.00695	CcSEcCtD
Oxprenolol—Insomnia—Donepezil—Alzheimer's disease	0.000728	0.0069	CcSEcCtD
Oxprenolol—Thrombocytopenia—Memantine—Alzheimer's disease	0.000715	0.00678	CcSEcCtD
Oxprenolol—Diarrhoea—Galantamine—Alzheimer's disease	0.00071	0.00673	CcSEcCtD
Oxprenolol—Dyspepsia—Donepezil—Alzheimer's disease	0.000708	0.00671	CcSEcCtD
Oxprenolol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000706	0.00669	CcSEcCtD
Oxprenolol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.0007	0.00663	CcSEcCtD
Oxprenolol—Fatigue—Donepezil—Alzheimer's disease	0.000694	0.00658	CcSEcCtD
Oxprenolol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000691	0.00655	CcSEcCtD
Oxprenolol—Dizziness—Galantamine—Alzheimer's disease	0.000686	0.00651	CcSEcCtD
Oxprenolol—Hypotension—Memantine—Alzheimer's disease	0.000682	0.00647	CcSEcCtD
Oxprenolol—Hypotension—Rivastigmine—Alzheimer's disease	0.000668	0.00633	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000665	0.00631	CcSEcCtD
Oxprenolol—Insomnia—Memantine—Alzheimer's disease	0.000661	0.00626	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000651	0.00617	CcSEcCtD
Oxprenolol—Headache—Galantamine—Alzheimer's disease	0.00065	0.00617	CcSEcCtD
Oxprenolol—Insomnia—Rivastigmine—Alzheimer's disease	0.000646	0.00613	CcSEcCtD
Oxprenolol—Dyspepsia—Memantine—Alzheimer's disease	0.000643	0.0061	CcSEcCtD
Oxprenolol—Abdominal pain—Donepezil—Alzheimer's disease	0.000636	0.00603	CcSEcCtD
Oxprenolol—Fatigue—Memantine—Alzheimer's disease	0.00063	0.00597	CcSEcCtD
Oxprenolol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000629	0.00596	CcSEcCtD
Oxprenolol—Nausea—Galantamine—Alzheimer's disease	0.000617	0.00585	CcSEcCtD
Oxprenolol—Fatigue—Rivastigmine—Alzheimer's disease	0.000616	0.00584	CcSEcCtD
Oxprenolol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000593	0.00562	CcSEcCtD
Oxprenolol—Abdominal pain—Memantine—Alzheimer's disease	0.000577	0.00547	CcSEcCtD
Oxprenolol—Asthenia—Donepezil—Alzheimer's disease	0.000577	0.00547	CcSEcCtD
Oxprenolol—Pruritus—Donepezil—Alzheimer's disease	0.000569	0.0054	CcSEcCtD
Oxprenolol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000565	0.00536	CcSEcCtD
Oxprenolol—Diarrhoea—Donepezil—Alzheimer's disease	0.00055	0.00522	CcSEcCtD
Oxprenolol—Hypersensitivity—Memantine—Alzheimer's disease	0.000538	0.0051	CcSEcCtD
Oxprenolol—Dizziness—Donepezil—Alzheimer's disease	0.000532	0.00504	CcSEcCtD
Oxprenolol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000526	0.00499	CcSEcCtD
Oxprenolol—Asthenia—Memantine—Alzheimer's disease	0.000524	0.00497	CcSEcCtD
Oxprenolol—Pruritus—Memantine—Alzheimer's disease	0.000517	0.0049	CcSEcCtD
Oxprenolol—Asthenia—Rivastigmine—Alzheimer's disease	0.000513	0.00486	CcSEcCtD
Oxprenolol—Pruritus—Rivastigmine—Alzheimer's disease	0.000506	0.00479	CcSEcCtD
Oxprenolol—Headache—Donepezil—Alzheimer's disease	0.000504	0.00478	CcSEcCtD
Oxprenolol—Diarrhoea—Memantine—Alzheimer's disease	0.0005	0.00474	CcSEcCtD
Oxprenolol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000489	0.00464	CcSEcCtD
Oxprenolol—Dizziness—Memantine—Alzheimer's disease	0.000483	0.00458	CcSEcCtD
Oxprenolol—Nausea—Donepezil—Alzheimer's disease	0.000478	0.00453	CcSEcCtD
Oxprenolol—Dizziness—Rivastigmine—Alzheimer's disease	0.000472	0.00448	CcSEcCtD
Oxprenolol—Headache—Memantine—Alzheimer's disease	0.000458	0.00434	CcSEcCtD
Oxprenolol—Headache—Rivastigmine—Alzheimer's disease	0.000448	0.00424	CcSEcCtD
Oxprenolol—Nausea—Memantine—Alzheimer's disease	0.000434	0.00411	CcSEcCtD
Oxprenolol—Nausea—Rivastigmine—Alzheimer's disease	0.000424	0.00402	CcSEcCtD
Oxprenolol—Betaxolol—CYP2D6—Alzheimer's disease	0.000376	0.179	CrCbGaD
Oxprenolol—Bisoprolol—CYP2D6—Alzheimer's disease	0.000363	0.173	CrCbGaD
Oxprenolol—Acebutolol—CYP2D6—Alzheimer's disease	0.000344	0.164	CrCbGaD
Oxprenolol—Alprenolol—CYP2D6—Alzheimer's disease	0.000312	0.149	CrCbGaD
Oxprenolol—Metoprolol—CYP2D6—Alzheimer's disease	0.00029	0.138	CrCbGaD
Oxprenolol—Pindolol—CYP2D6—Alzheimer's disease	0.000269	0.128	CrCbGaD
Oxprenolol—Propranolol—CYP2D6—Alzheimer's disease	0.000146	0.0698	CrCbGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GAL—Alzheimer's disease	3.97e-05	0.00135	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—CALM1—Alzheimer's disease	3.97e-05	0.00135	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	3.96e-05	0.00135	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP46A1—Alzheimer's disease	3.93e-05	0.00134	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ND1—Alzheimer's disease	3.8e-05	0.00129	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GAL—Alzheimer's disease	3.68e-05	0.00125	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GAL—Alzheimer's disease	3.6e-05	0.00123	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TTR—Alzheimer's disease	3.59e-05	0.00122	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	3.57e-05	0.00122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TTR—Alzheimer's disease	3.51e-05	0.0012	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	3.49e-05	0.00119	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—CREB1—Alzheimer's disease	3.39e-05	0.00116	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—NPY—Alzheimer's disease	3.19e-05	0.00108	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	3.18e-05	0.00108	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—CCR5—Alzheimer's disease	3.17e-05	0.00108	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—IAPP—Alzheimer's disease	3.17e-05	0.00108	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PYY—Alzheimer's disease	3.14e-05	0.00107	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—NPY—Alzheimer's disease	3.12e-05	0.00106	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	3.11e-05	0.00106	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HTR2A—Alzheimer's disease	3.1e-05	0.00106	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	3.1e-05	0.00106	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	3.1e-05	0.00105	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CRH—Alzheimer's disease	3.07e-05	0.00105	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	3.07e-05	0.00105	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	3.04e-05	0.00103	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	3.04e-05	0.00103	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	3.01e-05	0.00102	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—NPS—Alzheimer's disease	2.91e-05	0.000992	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	2.89e-05	0.000985	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	2.88e-05	0.000979	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	2.85e-05	0.000971	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	2.83e-05	0.000964	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	2.81e-05	0.000958	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	2.79e-05	0.000951	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	2.78e-05	0.000947	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	2.78e-05	0.000947	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.77e-05	0.000944	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	2.73e-05	0.00093	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	2.72e-05	0.000927	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	2.72e-05	0.000926	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	2.72e-05	0.000926	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	2.72e-05	0.000926	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	2.71e-05	0.000923	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	2.66e-05	0.000907	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	2.66e-05	0.000906	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	2.65e-05	0.000902	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	2.65e-05	0.000901	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.63e-05	0.000897	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	2.62e-05	0.000892	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	2.59e-05	0.000882	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.58e-05	0.000879	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.58e-05	0.000877	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	2.56e-05	0.000873	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.56e-05	0.00087	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	2.52e-05	0.00086	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	2.52e-05	0.00086	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.5e-05	0.000852	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	2.47e-05	0.000841	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	2.47e-05	0.000841	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	2.46e-05	0.000838	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TPI1—Alzheimer's disease	2.45e-05	0.000834	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CHAT—Alzheimer's disease	2.45e-05	0.000834	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	2.43e-05	0.000826	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	2.42e-05	0.000825	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	2.41e-05	0.00082	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	2.38e-05	0.00081	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	2.37e-05	0.000807	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MAOB—Alzheimer's disease	2.35e-05	0.000799	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	2.35e-05	0.000799	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	2.33e-05	0.000792	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	2.32e-05	0.00079	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	2.3e-05	0.000783	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	2.3e-05	0.000781	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	2.28e-05	0.000778	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	2.27e-05	0.000773	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GAPDH—Alzheimer's disease	2.26e-05	0.000769	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	2.23e-05	0.000761	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	2.23e-05	0.000759	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	2.2e-05	0.000747	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—A2M—Alzheimer's disease	2.18e-05	0.000743	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	2.18e-05	0.000742	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	2.18e-05	0.000741	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	2.18e-05	0.000741	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	2.13e-05	0.000725	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	2.13e-05	0.000725	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	2.1e-05	0.000716	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	2.03e-05	0.00069	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.96e-05	0.000666	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	1.92e-05	0.000653	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ACHE—Alzheimer's disease	1.9e-05	0.000646	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.89e-05	0.000644	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—INPP5D—Alzheimer's disease	1.88e-05	0.000639	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	1.88e-05	0.000639	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	1.86e-05	0.000632	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.85e-05	0.00063	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	1.82e-05	0.000619	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.79e-05	0.00061	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS1—Alzheimer's disease	1.78e-05	0.000606	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ENO1—Alzheimer's disease	1.78e-05	0.000606	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.75e-05	0.000597	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.75e-05	0.000597	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2D6—Alzheimer's disease	1.74e-05	0.000594	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.72e-05	0.000585	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.72e-05	0.000584	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	1.71e-05	0.000582	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	1.7e-05	0.000578	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.68e-05	0.000572	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	1.67e-05	0.000569	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	1.66e-05	0.000566	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—BCHE—Alzheimer's disease	1.65e-05	0.000563	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	1.65e-05	0.000562	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	1.63e-05	0.000554	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	1.61e-05	0.000549	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.59e-05	0.000542	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	1.59e-05	0.000542	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	1.56e-05	0.000532	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PLCB1—Alzheimer's disease	1.56e-05	0.000531	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.56e-05	0.00053	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.56e-05	0.00053	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.54e-05	0.000523	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.53e-05	0.000522	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	1.53e-05	0.000521	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.52e-05	0.000518	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ABCA1—Alzheimer's disease	1.51e-05	0.000515	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	1.5e-05	0.000512	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	1.5e-05	0.000511	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.49e-05	0.000508	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.49e-05	0.000508	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.49e-05	0.000508	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.49e-05	0.000506	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.48e-05	0.000503	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	1.46e-05	0.000497	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	1.46e-05	0.000497	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	1.46e-05	0.000497	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.45e-05	0.000495	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	1.45e-05	0.000495	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.45e-05	0.000492	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.42e-05	0.000484	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.4e-05	0.000475	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.37e-05	0.000467	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.37e-05	0.000465	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.34e-05	0.000457	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARGC1A—Alzheimer's disease	1.3e-05	0.000444	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMOX1—Alzheimer's disease	1.3e-05	0.000442	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.28e-05	0.000436	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.27e-05	0.000433	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.26e-05	0.000429	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.26e-05	0.000429	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.25e-05	0.000426	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.25e-05	0.000426	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.24e-05	0.000424	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.24e-05	0.000424	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.22e-05	0.000416	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.22e-05	0.000414	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.21e-05	0.000412	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LPL—Alzheimer's disease	1.19e-05	0.000404	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	1.18e-05	0.000402	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.16e-05	0.000396	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	1.16e-05	0.000394	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	1.13e-05	0.000383	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.12e-05	0.000383	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	1.1e-05	0.000375	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	1.09e-05	0.00037	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—Alzheimer's disease	1.07e-05	0.000364	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	1.06e-05	0.000362	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	1.04e-05	0.000355	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	1.03e-05	0.000352	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	1.02e-05	0.000347	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	1.01e-05	0.000345	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	1.01e-05	0.000344	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CALM1—Alzheimer's disease	9.99e-06	0.00034	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOE—Alzheimer's disease	9.95e-06	0.000339	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	9.92e-06	0.000338	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	9.88e-06	0.000336	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CAV1—Alzheimer's disease	9.86e-06	0.000336	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	9.78e-06	0.000333	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	9.67e-06	0.000329	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	9.66e-06	0.000329	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	9.61e-06	0.000327	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	9.41e-06	0.00032	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	9.4e-06	0.00032	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	9.2e-06	0.000313	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	9.16e-06	0.000312	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	9.16e-06	0.000312	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	8.78e-06	0.000299	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	8.74e-06	0.000298	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	8.74e-06	0.000298	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARG—Alzheimer's disease	8.67e-06	0.000295	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	8.66e-06	0.000295	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	8.58e-06	0.000292	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	8.55e-06	0.000291	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	8.55e-06	0.000291	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	8.52e-06	0.00029	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—INS—Alzheimer's disease	8.5e-06	0.000289	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	8.48e-06	0.000289	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	8.35e-06	0.000284	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	8.25e-06	0.000281	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	8.17e-06	0.000278	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	8.07e-06	0.000275	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	8.07e-06	0.000275	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	8.04e-06	0.000274	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	7.89e-06	0.000269	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	7.79e-06	0.000265	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	7.57e-06	0.000258	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	7.51e-06	0.000256	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	7.47e-06	0.000254	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NOS3—Alzheimer's disease	7.46e-06	0.000254	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	7.41e-06	0.000252	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	7.35e-06	0.00025	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	7.35e-06	0.00025	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	7.31e-06	0.000249	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	7.23e-06	0.000246	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	7.19e-06	0.000245	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	7.07e-06	0.000241	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	6.82e-06	0.000232	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	6.71e-06	0.000229	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	6.68e-06	0.000228	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	6.55e-06	0.000223	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	6.41e-06	0.000218	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPL—Alzheimer's disease	6.11e-06	0.000208	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.61e-06	0.000191	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	5.56e-06	0.000189	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	5.53e-06	0.000188	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.5e-06	0.000187	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.49e-06	0.000187	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	5.44e-06	0.000185	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	5.41e-06	0.000184	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	5.14e-06	0.000175	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOE—Alzheimer's disease	5.12e-06	0.000174	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	5.11e-06	0.000174	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	5.1e-06	0.000174	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	5.08e-06	0.000173	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	5e-06	0.00017	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	4.99e-06	0.00017	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	4.72e-06	0.000161	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	4.62e-06	0.000157	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.46e-06	0.000152	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—INS—Alzheimer's disease	4.38e-06	0.000149	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	4.33e-06	0.000147	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	4.24e-06	0.000144	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.84e-06	0.000131	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	3.57e-06	0.000121	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.51e-06	0.00012	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	3.49e-06	0.000119	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—Alzheimer's disease	3.43e-06	0.000117	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	3.26e-06	0.000111	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	3.19e-06	0.000109	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	3.01e-06	0.000103	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	2.95e-06	0.0001	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.76e-06	6.01e-05	CbGpPWpGaD
